The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AETNA INC NEW | COM | 00817Y108 | 15,835 | 86,296 | SH | SOLE | 86,296 | 0 | 0 | ||
| BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 7,373 | 39,500 | SH | SOLE | 39,500 | 0 | 0 | ||
| INTREXON CORP | COM | 46122T102 | 6,034 | 432,878 | SH | SOLE | 432,878 | 0 | 0 | ||
| JPMORGAN CHASE & CO | COM | 46625H100 | 32,703 | 313,853 | SH | SOLE | 313,853 | 0 | 0 | ||
| PVH CORP | COM | 693656100 | 7,934 | 52,995 | SH | SOLE | 52,995 | 0 | 0 | ||
| ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 202 | 66,749 | SH | SOLE | 66,749 | 0 | 0 | ||